A Study of the Effectiveness of Stress Management Therapy for Patients with Melanoma


About this study

The purpose of this study is to test a particular stress management therapy program for effectiveness in decreasing stress, increasing quality of life, and improving the immune system in patients with melanoma.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Current or new diagnosis of melanoma (stage 0-IV)
  • Adult over the age of 18
  • Able and willing to participate in all aspects of the study
  • Provided with, understood, and signed the appropriate informed consent form


Exclusion Criteria 

  • Recent (within the past 6 months) psychotic episode
  • Clinically significant acute unstable neurologic, psychiatric, hepatic, renal, cardiovascular, or respiratory disease that prevents participation in the study


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Amer Kalaaji, M.D.

Closed for enrollment

Contact information:

Katrina Pierce CCRP

(507) 266-1078


More information


Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions